Article
This trial will determine if a new imaging technique will be able to localize the source of ectopic ACTH production.
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Study Type: Observational
Age/Gender Requirements: 18-70 years (male/female)
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development
Purpose: To determine “whether [18-F]-fluorodeoxyglucose (FDG) or use of a higher dose of [111In-DTPA-D-Phe]-pentetreotide can be used to successfully localize the source of ectopic ACTH production.”
Click here to access this third-party resource.
FDA Approves Crinecerfont for Congenital Adrenal Hyperplasia